Inventor · disambiguated record
Wendy Eccles
Also filed as: ECCLES WENDY · ECCLES WENDY K
21 granted patents·2 pending applications·49 citations·filing 2006–2023
93Inventor score
Top patents by PatentIndex Score
23 records- 0187US11254673B2Small molecule inhibitors of NF-κB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2020·Granted Feb 22, 2022·2 cites·13 claims
- 0286US9079866B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 14, 2015·8 cites·7 claims
- 0385US9073876B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 7, 2015·6 cites·7 claims
- 0484US7935725B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 3, 2011·6 cites·16 claims
- 0582US9265770B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 23, 2016·3 cites·11 claims
- 0681US8952177B21,2,6-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Feb 10, 2015·4 cites·9 claims
- 0781US8367719B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 5, 2013·5 cites·21 claims
- 0880US9067917B21,2,5-substituted benzimidazoles as FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 30, 2015·3 cites·9 claims
- 0979US9089569B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 28, 2015·3 cites·13 claims
- 1079US8344008B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 1, 2013·5 cites·4 claims
- 1176US2024199605A1SMALL MOLECULAR INHIBITORS OF NF-kB INDUCING KINASEJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1275US11827634B2Small molecule inhibitors of NF-kB inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2021·Granted Nov 28, 2023·0 cites·31 claims
- 1372US9926333B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Mar 27, 2018·1 cites·8 claims
- 1472US9732093B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 15, 2017·1 cites·18 claims
- 1571US9884878B2FLAP modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Feb 6, 2018·1 cites·6 claims
- 1671US9745328B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Aug 29, 2017·1 cites·16 claims
- 1762US2025282785A1Pyrrolidinone derivatives as inhibitors of nf kappa b inducing kinaseJANSSEN PHARMACEUTICA NV·Filed 2023·Application pending·0 cites
- 1861US9682971B21,2,5-Substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jun 20, 2017·0 cites·13 claims
- 1960US10047101B2Flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2017·Granted Aug 14, 2018·0 cites·5 claims
- 2059US9695149B21,2,6-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2014·Granted Jul 4, 2017·0 cites·20 claims
- 2152US9682972B21,2,5-substituted benzimidazoles as flap modulatorsJANSSEN PHARMACEUTICA NV·Filed 2015·Granted Jun 20, 2017·0 cites·12 claims
- 2250US7378552B2Monoamine re-uptake inhibitors and methods relating theretoNEUROCRINE BIOSCIENCES INC·Filed 2006·Granted May 27, 2008·0 cites·15 claims
- 2328US8399465B2Compounds with two fused bicyclic heteroaryl moieties as modulators of leukotriene A4 hydrolaseBACANI GENESIS·Filed 2010·Granted Mar 19, 2013·0 cites·54 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →